BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12568205)

  • 1. An open comparative clinical trial to assess the efficacy and safety of losartan versus enalapril in mild to moderate hypertension.
    Chowta KN; Chowta MN; Bhat P; Adhikari PM
    J Assoc Physicians India; 2002 Oct; 50():1236-9. PubMed ID: 12568205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative evaluation of therapeutic effects of once a day dose of losartan potassium versus enalapril maleate in mild to moderate essential hypertension.
    Neki NS; Arora P
    J Indian Med Assoc; 2001 Nov; 99(11):640-1. PubMed ID: 12022207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of efficacy and tolerability of Losartan and Ramipril combination in the management of hypertensive patients with associated diabetes mellitus in India (LORD Trial).
    Joshi SR; Yeolekar ME; Tripathi KK; Giri J; Maity AK; Chopda M; Gujarathi S; Maroli S; Maity A;
    J Assoc Physicians India; 2004 Mar; 52():189-95. PubMed ID: 15636307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.
    Pareek A; Basavanagowdappa H; Zawar S; Kumar A; Chandurkar N
    Expert Opin Pharmacother; 2009 Jul; 10(10):1529-36. PubMed ID: 19514864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical efficacy and tolerability of the angiotensin II-receptor antagonist losartan in Japanese patients with hypertension.
    Ogihara T; Yoshinaga K
    Blood Press Suppl; 1996; 2():78-81. PubMed ID: 8913545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension.
    Breeze E; Rake EC; Donoghue MD; Fletcher AE
    J Hum Hypertens; 2001 Dec; 15(12):857-62. PubMed ID: 11773988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan with hydrochlorothiazide in the treatment of hypertension.
    Schoenberger JA;
    J Hypertens Suppl; 1995 Jul; 13(1):S43-7. PubMed ID: 18800455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of efficacy and safety of losartan potassium in the treatment of mild to moderate hypertension as compared to enalapril maleate.
    Shobha JC; Kumar TR; Raju BS; Kamath S; Rao M; Harwal ; Babu A; Bhaduri J
    J Assoc Physicians India; 2000 May; 48(5):497-500. PubMed ID: 11273142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of losartan-amplodipine combination--an Indian postmarketing surveillance experience.
    Gokhale N; Shahani S; Pawar D
    J Indian Med Assoc; 2002 Mar; 100(3):207-8. PubMed ID: 12408291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of enalapril versus extended-release nifedipine for the treatment of mild-to-moderate essential hypertension: a multicenter 22-week study. Multicenter Cooperative Study Group.
    Leon AS
    Clin Ther; 1993; 15(6):1094-107. PubMed ID: 8111807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiproteinuric effect of losartan is systemic blood pressure dependent.
    Crowe AV; Howse M; Vinjamuri S; Kemp GJ; Williams PS
    Nephrol Dial Transplant; 2003 Oct; 18(10):2160-4. PubMed ID: 13679496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S; Mahajan SK; Sen R; Sharma A
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension.
    James IG; Jones A; Davies P
    J Hum Hypertens; 2002 Aug; 16(8):605-10. PubMed ID: 12149668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.